Pharmaceuticals Industry in India

India is among the world's largest suppliers of generic medicines and bulk drugs, selling finished formulations at home and to regulated markets abroad while building active ingredients, biologics and complex generics. This page measures the whole industry, listed and private drug makers together, from statutory filings and exchange prices, and sets it against related industries, buyer searches, news, geography and the wider pharmaceutical ecosystem.

Top pharmaceuticals companies in India (listed and private)

Frequently asked questions

How large is the pharmaceuticals industry in India?

2253 pharmaceuticals companies with statutory filings (103 listed, 2150 private) reported combined revenue of ₹6.20 lakh crore in FY2025, +9.6% on the same companies, and aggregate EBITDA of ₹1.48 lakh crore. As filed each year, combined revenue was ₹2.68 lakh crore in FY2018, reached ₹6.20 lakh crore in FY2025, the highest in the period; year-on-year changes are measured on the same companies. The 69 listed companies with an exchange price are worth ₹20.66 lakh crore in market capitalisation. Size here is measured in revenue, profit and market value, from statutory filings and exchange prices, not in physical volume of output.

Is profitability improving or deteriorating?

Improving. The aggregate EBITDA margin of pharmaceuticals companies was 23.8% in FY2025, 1.5 pts above FY2024, the highest in the period. Profit after tax margin was 14.0% (+2.2 pts on FY2024). Aggregate EBITDA of listed and private pharma companies moved +47% from FY2022 to FY2025 on a same-company basis; FY2025 EBITDA was ₹1.48 lakh crore (+14.6% on FY2024).

Which companies are leading the pharmaceuticals industry?

By FY2025 revenue the largest pharmaceuticals companies are Sun Pharma (₹52,578 crore, 32.8% EBITDA margin); Dr. Reddy's Laboratories (₹32,644 crore, 29.5% EBITDA margin); Aurobindo Pharma (₹31,724 crore, 22.7% EBITDA margin); Cipla (₹27,548 crore, 29.0% EBITDA margin); Zydus Lifesciences (₹23,242 crore, 31.5% EBITDA margin). Among the ten largest, Sun Pharma (32.8%) and Zydus Lifesciences (31.5%) earn the widest EBITDA margins and Hetero Labs (17.2%) the thinnest. 6 of the 25 largest are private companies, which a listed-only view leaves out.

Where is demand or investment changing?

In the news: Net tone of patents and legal disputes stories fell from +36 to +26 (-10 pts) over 306 stories, the largest drop of any theme. In buyer searches: Search interest in vitamins, calcium and wellness tablets queries (vitamin c tablet, vitamin c tablets, folic acid tablet) was +6% in the 12 months to 2026-09 vs the prior 12, led by “vitamin c tablet” (+21%), followed by medicine prices, generics and substitutes (+2%); pain and fever medicines moved -16%.

What should I investigate next?

These are the findings that fired on the data, negative signals first, each with the topic that holds the evidence: Coverage of patents and legal disputes turned more negative (Pharmaceuticals in the news). Pharmaceuticals EBITDA grew 47% since FY2022 (Industry financials). 47 private pharma manufacturers pass an IPO-readiness screen (Top pharmaceuticals companies in India). Vitamins, calcium and wellness tablets searches rose most in the last year (Search & demand signals). Median EV/EBITDA is 19.0× and median P/E 31.8× across 69 priced pharmaceuticals companies. (Market capitalisation & valuation).

How are pharmaceuticals stocks valued?

The median trailing P/E is 31.8× and the median EV/EBITDA 19.0× across 69 priced companies.

What is the pharmaceuticals industry?

The pharmaceutical industry develops and makes medicines: finished formulations such as tablets, capsules, injectables, syrups and ointments, the active pharmaceutical ingredients and bulk drugs that go into them, and biologics such as vaccines and biosimilars, sold through chemists, hospitals and institutions at home and abroad.

What does this page cover?

Listed and private drug makers whose registered industry code is pharmaceuticals, plus drug makers filed under neighbouring chemical codes that carry a pharmaceutical term in their name, reviewed by hand. Hospitals, diagnostics, medical devices, contract research and manufacturing organisations, pharmacies and distributors, herbal and wellness brands, agro and general-chemical look-alikes, and companies that report inside a listed parent's consolidated accounts are left out of the company totals; the ecosystem section still shows contract research and manufacturing, devices, diagnostics and hospital supply as separate sub-sectors.

Research information, not investment advice.